A Documentary Film THE GREATER GOOD looks behind the fear, hype and politics that have polarized the vaccine debate in America today. The film re-frames the emotionally charged issue and offers, for the first time, the opportunity for a rational and scientific discussion on how to create a safer and more effective vaccine program. Latest […]
Recognition and Management of Anaphylaxis to Vaccines
Anaphylaxis to Vaccines Mary S. Hayney, PharmD, MPH, FCCP, BCPS Introduction Anaphylaxis following immunization is very rare—about one case per 1.5 million doses of vaccine. However, immunizing pharmacists must be ready to respond quickly with each immunization, because anaphylaxis can occur without warning at any time. Classic anaphylaxis is mediated by a class of antibodies […]
Multiple studies link autism to mercury, which is still present in most flu vaccines
By Ethan A. Huff, Staff Writer (NaturalNews) Despite recommendations made by the US Centers for Disease Control and Prevention (CDC) in 1999 that Thimerosal, a mercury-based preservative, be removed from vaccines, the toxic chemical is still added to the majority of flu vaccines administered to women, children, and the elderly, according to the Coalition for […]
NVIC's "Ask Nurse Vicky" Educates Consumers
NVIC’s “Ask Nurse Vicky March 10, 2011 NVIC’s “Ask Nurse Vicky” Educates Consumers A new online video health education program produced by the National Vaccine Information Center (NVIC) will feature Vicky Debold, RN, PhD, responding to letters from consumers asking questions about vaccination. Since its founding in 1982, NVIC has responded to letters and telephone […]
Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
NEW YORK, March 9, 2011 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
http://www.reportlinker.com/p0312154/Cancer-Vaccines—Pipeline-Assessment-and-Market-Forecasts-to-2017.html
Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global Cancer vaccines market. The report identifies key trends shaping and driving the global Atopic dermatitis disease market. It also provides insight on the prevalent competitive landscape and the emerging players expected to bring a significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Cancer vaccines sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research, and in house analysis by GlobalData’s team of industry experts.
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 78
- Next Page »
